Breaking News Instant updates and real-time market news.

XENE

Xenon Pharmaceuticals

$13.99 /

+1.36 (+10.77%)

19:57
05/31/20
05/31
19:57
05/31/20
19:57

Xenon Pharmaceuticals assumed with a Buy at Jefferies

Jefferies analyst Andrew Tsai assumed coverage of Xenon Pharmaceuticals with a Buy rating with a price target of $23, up from $16. The analyst believes that Phase IIb data in the first half of 2021 for XEN1101 in broad seizures has a 50% chance to push the stock up 50%-75%. Tsai also thinks Phase III-ready XEN496 for rare pediatric epilepsy has a similar chance of success.

XENE Xenon Pharmaceuticals
$13.99 /

+1.36 (+10.77%)

03/25/20
Fly Intel: Top five analyst initiations
03/24/20 Wedbush
Xenon Pharmaceuticals initiated with an Outperform at Wedbush
03/24/20 Wedbush
Xenon Pharmaceuticals initiated with an Outperform at Wedbush
01/08/20 William Blair
Xenon Pharmaceuticals initiated with an Outperform at William Blair

TODAY'S FREE FLY STORIES

General news
Treasury Market Outlook: stocks are giving back some of Monday's gains » 07:45
07/07/20
07/07
07:45
07/07/20
07:45

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Bed Bath & Beyond price target raised to $13 from $9 at Raymond James » 07:44
07/07/20
07/07
07:44
07/07/20
07:44
BBBY

Bed Bath & Beyond

$10.77 /

-0.055 (-0.51%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBBY Bed Bath & Beyond
$10.77 /

-0.055 (-0.51%)

BBBY Bed Bath & Beyond
$10.77 /

-0.055 (-0.51%)

05/26/20 Odeon Capital
Bed Bath & Beyond upgraded to Buy from Hold at Odeon Capital
04/16/20 Loop Capital
Bed Bath & Beyond Q4 results 'less bad than feared' says Loop Capital
04/08/20 Loop Capital
Bed Bath & Beyond price target lowered to $5 from $12 at Loop Capital
03/23/20 Odeon Capital
Bed Bath & Beyond downgraded to Hold from Buy at Odeon Capital
BBBY Bed Bath & Beyond
$10.77 /

-0.055 (-0.51%)

BBBY Bed Bath & Beyond
$10.77 /

-0.055 (-0.51%)

BBBY Bed Bath & Beyond
$10.77 /

-0.055 (-0.51%)

BBBY Bed Bath & Beyond
$10.77 /

-0.055 (-0.51%)

BBBY Bed Bath & Beyond
$10.77 /

-0.055 (-0.51%)

Initiation
Wedbush bullish on Generation Bio, initiates with an Outperform » 07:44
07/07/20
07/07
07:44
07/07/20
07:44
GBIO

Generation Bio

$19.94 /

+0.29 (+1.48%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GBIO Generation Bio
$19.94 /

+0.29 (+1.48%)

06:31 Today Wedbush
Generation Bio initiated with an Outperform at Wedbush
06:27 Today Cowen
Generation Bio initiated with an Outperform at Cowen
06:22 Today Jefferies
Generation Bio initiated with a Buy at Jefferies
  • 12
    Jun
GBIO Generation Bio
$19.94 /

+0.29 (+1.48%)

Recommendations
Apple price target raised to $400 from $340 at Raymond James » 07:43
07/07/20
07/07
07:43
07/07/20
07:43
AAPL

Apple

$373.86 /

+9.74 (+2.67%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$373.86 /

+9.74 (+2.67%)

AAPL Apple
$373.86 /

+9.74 (+2.67%)

07/06/20 Loop Capital
Apple's build plan update negates speculation of cut, says Loop Capital
06/26/20 Evercore ISI
Evercore upgrades Broadcom to Outperform, sees Apple sales driving upside
06/25/20 Wedbush
Wedbush boosts Apple target to $425, sees $2 trillion valuation in 2021
06/24/20 BMO Capital
Criteo downgraded to Market Perform from Outperform at BMO Capital
AAPL Apple
$373.86 /

+9.74 (+2.67%)

AAPL Apple
$373.86 /

+9.74 (+2.67%)

AAPL Apple
$373.86 /

+9.74 (+2.67%)

AAPL Apple
$373.86 /

+9.74 (+2.67%)

AAPL Apple
$373.86 /

+9.74 (+2.67%)

Recommendations
Equity Residential price target lowered to $70 from $90 at Argus » 07:41
07/07/20
07/07
07:41
07/07/20
07:41
EQR

Equity Residential

$59.61 /

-0.96 (-1.58%)

Argus analyst Jacob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EQR Equity Residential
$59.61 /

-0.96 (-1.58%)

EQR Equity Residential
$59.61 /

-0.96 (-1.58%)

06/29/20 Scotiabank
Scotiabank double downgrades Equity Residential on urban exposure
06/29/20 Scotiabank
Equity Residential downgraded to Underperform from Outperform at Scotiabank
05/18/20 BofA
BofA upgrades Camden Property to Buy, cuts Equity Residential, Aimco
05/18/20 BofA
Equity Residential downgraded to Neutral from Buy at BofA
EQR Equity Residential
$59.61 /

-0.96 (-1.58%)

EQR Equity Residential
$59.61 /

-0.96 (-1.58%)

Downgrade
CommScope downgraded to Market Perform at Raymond James on valuation » 07:41
07/07/20
07/07
07:41
07/07/20
07:41
COMM

CommScope

$8.68 /

+0.28 (+3.33%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COMM CommScope
$8.68 /

+0.28 (+3.33%)

COMM CommScope
$8.68 /

+0.28 (+3.33%)

04:43 Today Raymond James
CommScope downgraded to Market Perform from Outperform at Raymond James
07/06/20 Rosenblatt
Samsung on track to replace Nokia as 5G RAN supplier at Verizon, says Rosenblatt
06/25/20 Raymond James
CommScope price target lowered to $10 from $12 at Raymond James
05/05/20
Fly Intel: Top five analyst initiations
COMM CommScope
$8.68 /

+0.28 (+3.33%)

COMM CommScope
$8.68 /

+0.28 (+3.33%)

COMM CommScope
$8.68 /

+0.28 (+3.33%)

Hot Stocks
Hepion announces preclinical data supporting COVID-19 treatment with CRV431 » 07:40
07/07/20
07/07
07:40
07/07/20
07:40
HEPA

Hepion Pharmaceuticals

$2.88 /

+0.01 (+0.35%)

Hepion Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HEPA Hepion Pharmaceuticals
$2.88 /

+0.01 (+0.35%)

HEPA Hepion Pharmaceuticals
$2.88 /

+0.01 (+0.35%)

03/20/20 Roth Capital
Roth Capital says Hepion's CRV431 could be used in COVID-19 treatment
11/22/19 Brookline
Hepion Pharmaceuticals initiated with a Buy at Brookline
11/07/19
Fly Intel: Top analyst initiations
11/07/19 Roth Capital
Hepion Pharmaceuticals initiated with a Buy at Roth Capital
HEPA Hepion Pharmaceuticals
$2.88 /

+0.01 (+0.35%)

Periodicals
Deutsche Bank, Google agree to multi-year technology partnership, Reuters says » 07:39
07/07/20
07/07
07:39
07/07/20
07:39
DB

Deutsche Bank

$9.95 /

+0.405 (+4.25%)

, GOOG

Alphabet

$1,496.16 /

+31.05 (+2.12%)

, GOOGL

Alphabet Class A

$1,498.50 /

+27.74 (+1.89%)

Deutsche Bank (DB) has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DB Deutsche Bank
$9.95 /

+0.405 (+4.25%)

GOOG Alphabet
$1,496.16 /

+31.05 (+2.12%)

GOOGL Alphabet Class A
$1,498.50 /

+27.74 (+1.89%)

DB Deutsche Bank
$9.95 /

+0.405 (+4.25%)

07/02/20
Fly Intel: Top five analyst downgrades
07/01/20 Societe Generale
Deutsche Bank downgraded to Sell from Hold at Societe Generale
06/16/20 Barclays
Deutsche Bank price target raised to EUR 4 from EUR 3.50 at Barclays
06/16/20 JPMorgan
Deutsche Bank price target raised to EUR 7 from EUR 6.30 at JPMorgan
GOOG Alphabet
$1,496.16 /

+31.05 (+2.12%)

06/29/20 Stifel
Stifel says Facebook sales won't be materially hurt unless ad boycott broadens
06/25/20 Baird
Alphabet price target raised to $1,650 from $1,500 at Baird
06/24/20 Bernstein
Potential spinoff would be largely positive for VMware, says Bernstein
06/24/20 Goldman Sachs
Alphabet price target raised to $1,775 from $1,425 at Goldman Sachs
GOOGL Alphabet Class A
$1,498.50 /

+27.74 (+1.89%)

06/29/20 Stifel
Stifel says Facebook sales won't be materially hurt unless ad boycott broadens
06/25/20 Baird
Alphabet price target raised to $1,650 from $1,500 at Baird
06/24/20 Bernstein
Potential spinoff would be largely positive for VMware, says Bernstein
06/24/20 Goldman Sachs
Alphabet price target raised to $1,775 from $1,425 at Goldman Sachs
DB Deutsche Bank
$9.95 /

+0.405 (+4.25%)

GOOG Alphabet
$1,496.16 /

+31.05 (+2.12%)

GOOGL Alphabet Class A
$1,498.50 /

+27.74 (+1.89%)

DB Deutsche Bank
$9.95 /

+0.405 (+4.25%)

GOOG Alphabet
$1,496.16 /

+31.05 (+2.12%)

GOOGL Alphabet Class A
$1,498.50 /

+27.74 (+1.89%)

DB Deutsche Bank
$9.95 /

+0.405 (+4.25%)

GOOG Alphabet
$1,496.16 /

+31.05 (+2.12%)

GOOGL Alphabet Class A
$1,498.50 /

+27.74 (+1.89%)

DB Deutsche Bank
$9.95 /

+0.405 (+4.25%)

GOOG Alphabet
$1,496.16 /

+31.05 (+2.12%)

GOOGL Alphabet Class A
$1,498.50 /

+27.74 (+1.89%)

GOOG Alphabet
$1,496.16 /

+31.05 (+2.12%)

GOOGL Alphabet Class A
$1,498.50 /

+27.74 (+1.89%)

Downgrade
Healthcare Services downgraded to Market Perform from Outperform at Northland » 07:39
07/07/20
07/07
07:39
07/07/20
07:39
HCSG

Healthcare Services

$24.24 /

-0.05 (-0.21%)

Northland analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HCSG Healthcare Services
$24.24 /

-0.05 (-0.21%)

HCSG Healthcare Services
$24.24 /

-0.05 (-0.21%)

07/06/20 Benchmark
Healthcare Services downgraded to Hold from Buy at Benchmark
04/22/20 Credit Suisse
Healthcare Services price target lowered to $27 from $32 at Credit Suisse
04/20/20 Baird
Healthcare Services upgraded to Outperform from Neutral at Baird
02/25/20 Northland
Healthcare Services initiated with an Outperform at Northland
HCSG Healthcare Services
$24.24 /

-0.05 (-0.21%)

HCSG Healthcare Services
$24.24 /

-0.05 (-0.21%)

Initiation
Avidity Biosciences initiated with an Outperform at SVB Leerink » 07:38
07/07/20
07/07
07:38
07/07/20
07:38
RNA

Avidity Biosciences

$27.82 /

+0.715 (+2.64%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RNA Avidity Biosciences
$27.82 /

+0.715 (+2.64%)

RNA Avidity Biosciences
$27.82 /

+0.715 (+2.64%)

06:29 Today Cowen
Avidity Biosciences initiated with an Outperform at Cowen
06:25 Today Wells Fargo
Avidity Biosciences initiated with an Overweight at Wells Fargo
06:20 Today Credit Suisse
Avidity Biosciences initiated with an Outperform at Credit Suisse
  • 12
    Jun
RNA Avidity Biosciences
$27.82 /

+0.715 (+2.64%)

Recommendations
Ping Identity price target raised to $35 from $26 at Oppenheimer » 07:36
07/07/20
07/07
07:36
07/07/20
07:36
PING

Ping Identity

$32.81 /

+0.31 (+0.95%)

Oppenheimer analyst Shaul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PING Ping Identity
$32.81 /

+0.31 (+0.95%)

PING Ping Identity
$32.81 /

+0.31 (+0.95%)

06/24/20
Fly Intel: Top five analyst initiations
06/24/20 Baird
Ping Identity initiated with a Neutral at Baird
06/24/20 Goldman Sachs
Ping Identity price target raised to $35 from $22 at Goldman Sachs
06/23/20 Baird
Ping Identity initiated with a Neutral at Baird
PING Ping Identity
$32.81 /

+0.31 (+0.95%)

  • 09
    Jul
  • 14
    May
  • 19
    Sep
PING Ping Identity
$32.81 /

+0.31 (+0.95%)

PING Ping Identity
$32.81 /

+0.31 (+0.95%)

Hot Stocks
Turning Point Therapeutics, Zai Lab announce license agreement for repotrectinib » 07:36
07/07/20
07/07
07:36
07/07/20
07:36
TPTX

Turning Point Therapeutics

$62.75 /

-1.71 (-2.65%)

, ZLAB

Zai Lab

$82.11 /

+0.95 (+1.17%)

Turning Point…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TPTX Turning Point Therapeutics
$62.75 /

-1.71 (-2.65%)

ZLAB Zai Lab
$82.11 /

+0.95 (+1.17%)

TPTX Turning Point Therapeutics
$62.75 /

-1.71 (-2.65%)

05/26/20 H.C. Wainwright
Turning Point price target raised to $88 from $72 at H.C. Wainwright
05/14/20 Roth Capital
Turning Point Therapeutics price target raised to $75 from $65 at Roth Capital
05/14/20 Roth Capital
Turning Point Therapeutics price target raised to $75 from $65 at Roth Capital
05/13/20 SVB Leerink
Turning Point Therapeutics price target raised to $67 from $60 at SVB Leerink
ZLAB Zai Lab
$82.11 /

+0.95 (+1.17%)

07/06/20 Mizuho
Novocure has large growth opportunity in China, says Mizuho
05/13/20 Piper Sandler
Piper says Novocure opens up largest GBM market with China approval
05/06/20 H.C. Wainwright
Priority Review in China accelerates revenues for Paratek, says H.C. Wainwright
04/27/20
Zai Lab initiated with a Buy at Goldman Sachs
TPTX Turning Point Therapeutics
$62.75 /

-1.71 (-2.65%)

ZLAB Zai Lab
$82.11 /

+0.95 (+1.17%)

  • 19
    May
  • 23
    Jan
  • 06
    Sep
  • 01
    Aug
Hot Stocks
Nielsen raises FY20 pre-tax restructuring charges view to $150M-$170M » 07:35
07/07/20
07/07
07:35
07/07/20
07:35
NLSN

Nielsen

$15.04 /

+0.31 (+2.11%)

Nielsen Holdings …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NLSN Nielsen
$15.04 /

+0.31 (+2.11%)

NLSN Nielsen
$15.04 /

+0.31 (+2.11%)

05/28/20 Spin-Off Research
Nielsen upgraded to Hold from Sell at Spin-Off Research
05/21/20 Citi
Nielsen price target lowered to $18 from $28 at Citi
04/09/20 Arete
Nielsen downgraded to Sell from Neutral at Arete
02/28/20
Fly Intel: Top five analyst downgrades
NLSN Nielsen
$15.04 /

+0.31 (+2.11%)

NLSN Nielsen
$15.04 /

+0.31 (+2.11%)

NLSN Nielsen
$15.04 /

+0.31 (+2.11%)

NLSN Nielsen
$15.04 /

+0.31 (+2.11%)

Hot Stocks
Apollo announces 501k submission for X-Tack Endoscopic HeliX Tacking System » 07:35
07/07/20
07/07
07:35
07/07/20
07:35
APEN

Apollo Endosurgery

$1.71 /

+0.05 (+3.01%)

Apollo Endosurgery…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APEN Apollo Endosurgery
$1.71 /

+0.05 (+3.01%)

APEN Apollo Endosurgery
$1.71 /

+0.05 (+3.01%)

04/28/20 Piper Sandler
Apollo Endosurgery downgraded to Neutral from Overweight at Piper Sandler
03/27/20 Piper Sandler
Apollo Endosurgery price target lowered to $4.50 from $5.50 at Piper Sandler
11/18/19 Piper Jaffray
Apollo Endosurgery transferred with an Overweight rating at Piper Jaffray
11/18/19 Piper Jaffray
Apollo Endosurgery transferred with an Overweight rating at Piper Jaffray
Hot Stocks
Flotek regains NYSE compliance » 07:35
07/07/20
07/07
07:35
07/07/20
07:35
FTK

Flotek

$1.38 /

+0.11 (+8.66%)

Flotek Industries…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FTK Flotek
$1.38 /

+0.11 (+8.66%)

Options
Unusual call flow in option market yesterday » 07:35
07/07/20
07/07
07:35
07/07/20
07:35
MSFT

Microsoft

$210.72 /

+4.45 (+2.16%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$210.72 /

+4.45 (+2.16%)

MSFT Microsoft
$210.72 /

+4.45 (+2.16%)

07/06/20 Morgan Stanley
Microsoft skilling focus tempers some Pluralsight optimism, says Morgan Stanley
06/29/20 JMP Securities
ZoomInfo initiated with a Market Perform at JMP Securities
06/24/20 Bernstein
Potential spinoff would be largely positive for VMware, says Bernstein
06/24/20 Baird
Ping Identity initiated with a Neutral at Baird
MSFT Microsoft
$210.72 /

+4.45 (+2.16%)

MSFT Microsoft
$210.72 /

+4.45 (+2.16%)

MSFT Microsoft
$210.72 /

+4.45 (+2.16%)

MSFT Microsoft
$210.72 /

+4.45 (+2.16%)

MSFT Microsoft
$210.72 /

+4.45 (+2.16%)

Initiation
Azek initiated with a Buy at SunTrust » 07:34
07/07/20
07/07
07:34
07/07/20
07:34
AZEK

Azek

$31.59 /

-0.945 (-2.91%)

SunTrust analyst Keith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZEK Azek
$31.59 /

-0.945 (-2.91%)

06:36 Today BofA
Azek initiated with a Neutral at BofA
06:35 Today Stephens
Azek initiated with an Equal Weight at Stephens
06:23 Today Jefferies
Azek initiated with a Buy at Jefferies
06:22 Today RBC Capital
Azek initiated with an Outperform at RBC Capital
  • 12
    Jun
AZEK Azek
$31.59 /

-0.945 (-2.91%)

Hot Stocks
Leidos awarded new task order by the U.S. Army worth up to $210M » 07:34
07/07/20
07/07
07:34
07/07/20
07:34
LDOS

Leidos

$88.33 /

-5.39 (-5.75%)

Leidos announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LDOS Leidos
$88.33 /

-5.39 (-5.75%)

LDOS Leidos
$88.33 /

-5.39 (-5.75%)

06/11/20
Fly Intel: Top five analyst initiations
06/11/20 Baird
Baird starts Leidos at Outperform, sees growth poised to ramp next year
06/10/20 Baird
Leidos initiated with an Outperform at Baird
05/07/20
Fly Intel: Top five analyst initiations
LDOS Leidos
$88.33 /

-5.39 (-5.75%)

LDOS Leidos
$88.33 /

-5.39 (-5.75%)

LDOS Leidos
$88.33 /

-5.39 (-5.75%)

Hot Stocks
Hartford Financial extends COVID-19 personal auto payback plan » 07:33
07/07/20
07/07
07:33
07/07/20
07:33
HIG

Hartford Financial

$38.29 /

+0.81 (+2.16%)

The Hartford is extending…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HIG Hartford Financial
$38.29 /

+0.81 (+2.16%)

HIG Hartford Financial
$38.29 /

+0.81 (+2.16%)

05/05/20 Deutsche Bank
Hartford Financial price target lowered to $53 from $63 at Deutsche Bank
04/14/20 Morgan Stanley
Hartford Financial upgraded to Overweight from Equal Weight at Morgan Stanley
04/08/20 RBC Capital
Hartford Financial price target lowered to $39 from $66 at RBC Capital
04/01/20 Wells Fargo
Hartford Financial upgraded to Overweight from Equal Weight at Wells Fargo
HIG Hartford Financial
$38.29 /

+0.81 (+2.16%)

HIG Hartford Financial
$38.29 /

+0.81 (+2.16%)

HIG Hartford Financial
$38.29 /

+0.81 (+2.16%)

HIG Hartford Financial
$38.29 /

+0.81 (+2.16%)

Hot Stocks
Strongbridge Biopharma appoints John Johnson as CEO » 07:33
07/07/20
07/07
07:33
07/07/20
07:33
SBBP

Strongbridge Biopharma

$3.80 /

+0.13 (+3.54%)

Strongbridge Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SBBP Strongbridge Biopharma
$3.80 /

+0.13 (+3.54%)

SBBP Strongbridge Biopharma
$3.80 /

+0.13 (+3.54%)

03/03/20
Fly Intel: Top five analyst initiations
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
09/24/19 Evercore ISI
Strongbridge Biopharma initiated with an Outperform at Evercore ISI
SBBP Strongbridge Biopharma
$3.80 /

+0.13 (+3.54%)

Earnings
Rollins sees Q2 revenue growth 'low to mid-single digits,' consensus $487.52M » 07:32
07/07/20
07/07
07:32
07/07/20
07:32
ROL

Rollins

$42.73 /

-0.29 (-0.67%)

Rollins provided a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROL Rollins
$42.73 /

-0.29 (-0.67%)

ROL Rollins
$42.73 /

-0.29 (-0.67%)

06/05/20 Stifel
Rollins takeout seems unlikely given current valuation, says Stifel
11/21/19 Jefferies
Jefferies initiates Diversifed Services sector
11/21/19 Jefferies
Rollins initiated with a Hold at Jefferies
11/06/19
Fly Intel: Top five analyst upgrades
ROL Rollins
$42.73 /

-0.29 (-0.67%)

ROL Rollins
$42.73 /

-0.29 (-0.67%)

Hot Stocks
Novocure enrolls last patient in HEPANOVA trial » 07:32
07/07/20
07/07
07:32
07/07/20
07:32
NVCR

Novocure

$62.85 /

+2.21 (+3.64%)

Novocure announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVCR Novocure
$62.85 /

+2.21 (+3.64%)

NVCR Novocure
$62.85 /

+2.21 (+3.64%)

07/06/20 Mizuho
Novocure has large growth opportunity in China, says Mizuho
05/20/20 Piper Sandler
Novocure remains top idea in oncology equipment at Piper Sandler
05/13/20 Piper Sandler
Piper says Novocure opens up largest GBM market with China approval
05/01/20 SunTrust
Novocure price target lowered to $90 from $105 at SunTrust
NVCR Novocure
$62.85 /

+2.21 (+3.64%)

NVCR Novocure
$62.85 /

+2.21 (+3.64%)

Recommendations
Electronic Arts price target raised to $150 from $125 at Oppenheimer » 07:31
07/07/20
07/07
07:31
07/07/20
07:31
EA

Electronic Arts

$134.18 /

+0.48 (+0.36%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EA Electronic Arts
$134.18 /

+0.48 (+0.36%)

EA Electronic Arts
$134.18 /

+0.48 (+0.36%)

06/26/20 Needham
Electronic Arts price target raised to $150 from $135 at Needham
06/26/20 BMO Capital
Electronic Arts price target raised to $132 from $110 at BMO Capital
06/26/20 Stephens
Electronic Arts price target raised to $145 from $130 at Stephens
06/23/20 MKM Partners
Electronic Arts price target raised to $144 from $130 at MKM Partners
EA Electronic Arts
$134.18 /

+0.48 (+0.36%)

EA Electronic Arts
$134.18 /

+0.48 (+0.36%)

EA Electronic Arts
$134.18 /

+0.48 (+0.36%)

EA Electronic Arts
$134.18 /

+0.48 (+0.36%)

Hot Stocks
Kirkland Lake Gold sees FY20 gold production 1.35M-1.4M ounces  07:31
07/07/20
07/07
07:31
07/07/20
07:31
KL

Kirkland Lake Gold

$41.92 /

+0.285 (+0.68%)

 
ShowHide Related Items >><<
KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

06/11/20
Fly Intel: Top five analyst upgrades
06/11/20 Roth Capital
Kirkland Lake upgraded to Buy on higher gold prices at Roth Capital
06/11/20 Roth Capital
Kirkland Lake Gold upgraded to Buy from Neutral at Roth Capital
05/29/20 BMO Capital
Kirkland Lake Gold upgraded to Outperform from Market Perform at BMO Capital
KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

Downgrade
Illumina downgraded to Neutral following 81% rise off lows at Guggenheim » 07:31
07/07/20
07/07
07:31
07/07/20
07:31
ILMN

Illumina

$379.26 /

+6.62 (+1.78%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$379.26 /

+6.62 (+1.78%)

ILMN Illumina
$379.26 /

+6.62 (+1.78%)

06:09 Today Guggenheim
Illumina downgraded to Neutral from Buy at Guggenheim
07/02/20 JPMorgan
Illumina price target raised to $390 from $340 at JPMorgan
05/21/20 Argus
Illumina price target raised to $380 from $340 at Argus
05/01/20 Piper Sandler
Illumina price target lowered to $356 from $370 at Piper Sandler
ILMN Illumina
$379.26 /

+6.62 (+1.78%)

ILMN Illumina
$379.26 /

+6.62 (+1.78%)

ILMN Illumina
$379.26 /

+6.62 (+1.78%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.